Suppr超能文献

提高被动人体肠道吸收的观点。

Perspective on improving passive human intestinal absorption.

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA.

出版信息

J Pharm Sci. 2012 Sep;101(9):3047-50. doi: 10.1002/jps.23093. Epub 2012 Feb 28.

Abstract

Methods such as pH adjustment, cosolvency, complexation, and micellization are routinely used to increase the concentration of dissolved drug in the gastrointestinal (GI) lumen over that of a saturated solution. However, these solubilizing agents also reduce the membrane-water distribution coefficient so that the membrane transport rate is not changed. Also, dilution of a formulation upon administration results in: (1) a pH change toward that of the GI fluid, (2) an exponential decrease in cosolvency, and (3) disassociation of complexes and the disintegration of micelles. As a result, these solubilizing agents cannot be expected to produce any increase in membrane transport-limited drug absorption over that of a suspension of unformulated drug.

摘要

方法如 pH 值调节、共溶剂、络合作用和胶束化等,通常用于增加胃肠道(GI)腔内溶解药物的浓度,超过饱和溶液的浓度。然而,这些增溶剂也会降低膜-水分配系数,从而使膜转运速率不变。此外,制剂给药后的稀释会导致:(1)pH 值向胃肠道液体的方向变化,(2)共溶剂呈指数下降,以及(3)络合物的解离和胶束的崩解。因此,这些增溶剂不能期望比未成型药物的混悬液在膜转运受限药物吸收方面产生任何增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验